Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online September 1, 2021.
Article Versions
- You are currently viewing a Latest version of this article (September 1, 2021 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2021 The Journal of Rheumatology
Author Information
- Philip J. Mease,
- Robert R. McLean,
- Blessing Dube,
- Mei Liu,
- Sabrina Rebello,
- Meghan Glynn,
- Esther Yi,
- Yujin Park and
- Alexis Ogdie
- Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle, Washington; CorEvitas, LLC, Waltham, Massachusetts; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey; Division of Rheumatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
This study was sponsored by CorEvitas (formerly Corrona), LLC.
CorEvitas, LLC, has been supported through contracted subscriptions in the last 2 years by AbbVie, Amgen, Boehringer Ingelheim, BMS, Celgene, Crescendo, Eli Lilly and Company, Genentech, Gilead, GSK, Janssen, Merck, Momenta Pharmaceuticals, Novartis, Ortho Dermatologics, Pfizer Inc., Regeneron, Roche, Sun, and UCB. The design and conduct of the study were a collaborative effort between CorEvitas, LLC, and Novartis, and financial support for the study was provided by Novartis. Novartis participated in the interpretation of data and review and approval of the manuscript.
PJM has received research grants from AbbVie, Amgen, BMS, Galapagos, Gilead, Janssen, Lilly, Novartis, Pfizer, Sun, and UCB; and consulting and/or speakers bureau fees from AbbVie, Amgen, Boehringer Ingelheim, BMS, Galapagos, Genentech, Gilead, GSK, Janssen, Lilly, Novartis, Pfizer, Sun, and UCB. RRM and BD are employees of CorEvitas, LLC. ML, SR, and MG were employees of Corrona, LLC, at the time of this analysis. EY and YP are employees of Novartis Pharmaceuticals Corporation. AO has received consulting fees from Amgen, AbbVie, BMS, Celgene, Corrona, Janssen, Lilly, Novartis, and Pfizer; and grant support from the National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Psoriasis Foundation, Rheumatology Research Foundation, Pfizer (University of Pennsylvania), Amgen (FORWARD Databank), and Novartis (FORWARD Databank).
Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, WA 98122, USA. Email: pmease@philipmease.com.